Substituted 1h-imidazolyl pyrimidinylaminoethyl-2Methoxyacetamide compound
PK141091AUndetermined Publication Date: 2011-01-19NOVARTIS AG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200900253
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2011-01-19
Abstract
Disclosed is a new compound of Formula I and composition containing it. The new compound and composition may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Need to check novelty before this filing date? Find Prior Art